Seragon Pharmaceuticals

6 articles with Seragon Pharmaceuticals

• 

  Metacrine Closes $65 Million Series C Round

  6/6/2018

  Metracrine, based in San Diego, completed a Series C financing round worth $65 million.

• Stealth SoCal Startup Metacrine Eyes $33 Million and Talent-Cash From Seragon Alums?

  4/22/2015

• Seragon Pharmaceuticals Announces Closing Of Its Acquisition By Genentech

  8/28/2014

• Genentech To Pay Up To $1.7 Billion For San Diego Biotech Firm Seragon Pharmaceuticals

  7/7/2014

• Seragon Pharmaceuticals Appoints Debasish Roychowdhury, M.D. To Its Clinical And Scientific Advisory Board And As Acting Chief Medical Officer

  4/3/2014

• Startup Seragon Pharmaceuticals Lands $30 Million in Series A Financing

  10/16/2013